{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Pharm So Hard Ambulatory Care Podcast","title":"Episode 4. GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/0b9262bf\"></iframe>","width":"100%","height":180,"duration":2700,"description":"In this episode of the Pharm So Hard Podcast, the hosts discuss GLP-1 receptor agonists, a class of medications used to manage blood sugar levels in patients with type 2 diabetes and to treat obesity. They provide an overview of the history and development of GLP-1 receptor agonists, highlighting their clinical superiority and various benefits. The hosts also explain the role of GLP-1s in the body, including their glucose-dependent insulin secretion and effects on gastric emptying. They discuss the impact of GLP-1s on hunger and mental health, emphasizing the reduction of food noise and improvement in satiety levels. Additionally, they differentiate GLP-1 receptor agonists for diabetes and weight loss and explore their indications and guideline positioning. Takeaways \n\nGLP-1 receptor agonists are a class of medications used to manage blood sugar levels in patients with type 2 diabetes and to treat obesity.\n\n\nGLP-1 receptor agonists have shown clinical superiority to other anti-hyperglycemic drugs, improving glycemic control, reducing weight loss and blood pressure, and providing cardio-protective benefits.\n\n\nGLP-1s increase glucose-dependent insulin secretion, block glucagon secretion, and slow gastric emptying, leading to improved blood sugar control and increased satiety.\n\n\nGLP-1 receptor agonists have a positive impact on mental health, reducing food noise and helping individuals make healthier food choices.\n\n\nDifferent GLP-1 receptor agonists have specific indications for diabetes and weight loss, and their use is guided by clinical guidelines.\n\n\nGLP-1 receptor agonists are FDA-approved for improving glycemic control in patients with type 2 diabetes and for the treatment of obesity.\n\n\nThe choice of GLP-1 receptor agonist depends on factors such as comorbidities, weight loss goals, and patient preferences.\n\n\nGLP-1 receptor agonists have different dosing regimens, and the specific dose may vary based on the indication and the product.\n\n\nCommon side effects of...","thumbnail_url":"https://img.transistorcdn.com/nPa4eQh_Ojaw1p_aN3GLgdFwColnkJ0Xe-sQC4_xpbI/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8zYjhj/ODAyN2E4MmY3MGM1/ZmI4YmRiZmFjMjhh/Zjg0Yi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}